Navigation Links
arGEN-X Concludes EUR 12.5 Million Series A Financing Round
Date:12/3/2009

ROTTERDAM, The Netherlands, December 3 /PRNewswire/ -- arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful second closing of its Series A equity financing round. The Company raised an additional EUR 3.0 million (~USD 4.5 million) from two leading life science investors, Credit Agricole Private Equity and VIB (the prestigious Flemish research institute).

arGEN-X has raised a total of EUR 12.5million (~USD 18.7 million) from its completed Series A equity financing round, which was heavily oversubscribed.

Philippe Guinot, a senior partner at Credit Agricole Private Equity, joined the arGEN-X Supervisory Board.

The Series A round was co-led by Forbion Capital Partners (The Netherlands) and LSP (Life Sciences Partners - The Netherlands). Other members of the syndicate, which invested in the first closing of EUR 9.5 million, were KBC Private Equity (Belgium), BioGeneration Ventures (The Netherlands) and existing shareholders Erasmus MC Biomedical Fund and Thuja Capital Healthcare Funds.

arGEN-X will use the proceeds to further develop the Company's proprietary, unencumbered SIMPLE Antibody(TM) engine and to continue to build a proprietary pre-clinical antibody product portfolio. arGEN-X's SIMPLE Antibody(TM) platform yields monoclonal antibodies which combine an unparalleled functional diversity against human disease targets with best in class human germline homology. arGEN-X's SIMPLE Antibodies(TM) are generated in vivo, starting from active immunization, and exhibit ultra high starting affinities and potencies without the need for further engineering.

The arGEN-X platform has the potential to rapidly create exciting product candidates both against novel therapeutic targets and against targets where standard antibody approaches fail to
'/>"/>

SOURCE arGEN-X
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Phase IV Multi-center Clinical Study of Kutai Concludes in Nanjing
2. Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
3. Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
4. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
5. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
6. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
7. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
8. Russias Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013
9. For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult
10. Vermillion Files Plan of Reorganization
11. Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Professional Compounding Centers ... medicine by awarding the three best scientific presentations ... (EuPFI) conference . The Formulating Better Medicines ... in Athens, Greece , includes ... and professionals, from which three winners will be ...
(Date:8/21/2014)... MENLO PARK, Calif. , Aug. 21, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... ("Nat") Ricciardi to the Company,s newly expanded Board of ... now comprises eight directors, three of whom are independent. ... years of experience working with emerging growth companies. He ...
(Date:8/20/2014)... Aug. 20, 2014 The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down meth offenders and make arrests. Data released ... Kansas blocked the sale of more ...
Breaking Medicine Technology:Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 2011 Medizone International, Inc. (MZEI:OB MZEI:QB) reports ... Patent No 2735739 for processes and systems relating ... AsepticSure™ hospital disinfection product. Medizone,s ... significance of this Grant: "This foundational lead patent ...
... Leading event organiser UBM has announced a record ... pharmaceutical events including CPhI Worldwide for pharmaceutical ingredients, ... for equipment, machinery and technology and the new ... Frankfurt, Germany from the 25th to 27th October ...
Cached Medicine Technology:Canadian Patent Issued to Medizone International for AsepticSureā„¢ Disinfection Technology 2Record Year for UBM's Pharma Events in Frankfurt 2Record Year for UBM's Pharma Events in Frankfurt 3Record Year for UBM's Pharma Events in Frankfurt 4
(Date:8/21/2014)... Physicians (CHEST) announces the immediate release of Care ... and Disasters: CHEST Consensus Statement today in the ... while the global health-care community cares for ... aims to guide ethical decision-making, coordination of care, ... was developed by over 100 clinicians and experts ...
(Date:8/21/2014)... When children go back to school, they ... them to become sick and risk missing school. It is ... them fight these germs to ensure a successful school year. ... that with its XFactor program. , The XFactor program supports ... Children ages 4 and up can receive 30-day supplies of ...
(Date:8/21/2014)... 21, 2014 CarePoint Health is ... P. Patel, MD, and Sujoy Menon, MD, have ... Patel and Dr. Menon to the community. CarePoint ... diagnostic imaging services to patients in Hudson County ... Christ Hospital and Hoboken University Medical Center. Our ...
(Date:8/21/2014)... of Utah scientists have developed a genetically engineered line ... to new research on epilepsy, Alzheimer,s and other diseases. ... changes in degree of fluorescence in response to different ... cells called astrocytes and microglia, to be studied in ... possibility to decipher how the brain works," said ...
(Date:8/21/2014)... Individuals with schizophrenia often have trouble engaging in ... new study from San Francisco State University suggests the ... of effort required to complete tasks. , The research, ... Journal of Abnormal Psychology , can assist health ... and help those patients function normally by breaking up ...
Breaking Medicine News(10 mins):Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:MedX Pharmacy Helps with Back to School Preparation 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:Mouse model for epilepsy, Alzheimer's gives window into the working brain 2Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2
... Javier Menendez and colleagues from Northwestern University have found ... drug found to be effective in reducing the cancer ... have Her-2/neu receptors (Human Epidermal Growth factor Receptor type ... are more aggressive and the activation of the receptors ...
... name suggests is the excessive accumulation of fat in the ... may be a crucial one in explaining the association between ... concluded from the study that persons with fatty liver may ... ,The study was conducted among a group of 1,455 individuals ...
... Cape Town, South Africa have found effective results using ... women with high-risk for //,cervical cancer using low resource ... study results showed that the test and treat program ... of cervical cancer and precancerous cervical lesions. ...
... in action or effect of a particular drug than the individual ... in the present scenario where the avian bird flu is posing ... ,Tamiflu is a prescribed drug for seasonal flu, ... H5N1 bird flu circulating in Asia and reported in other areas ...
... Association for Cancer Research has leaned in a big way ... garlic after several studies presented at the meeting extolled on ... with irrefutable news, experts are now of the view that ... change the way you eat, in other words diet modification ...
... Delhi: India, which is currently ... flu, is thinking of importing ... for poultry said a government ... also has set up special ...
Cached Medicine News:Health News:Primrose oil reduces Breast cancer cell growth 2Health News:Persons With Fatty Liver More Prone For Hypertension 2Health News:Two screen test and treat screening for cervical cancer 2Health News:Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid 2
... plates in mind, Pipetman Ultra Multichannel ... applications: PCR* sequencing, immunology assays, series ... with Diamond Tips from Gilson's patented ... maximize performance and assure productivity.,* PCR ...
... variety of applications. • Whole pipette is autoclavable ... rotated against the handle to work in a ... towards the microtiter plate. • The special nose ... pipette tips, and provides a firm, parallel fit. ...
... precision, ergonomics, and value!, Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
... precision, ergonomics, and value!, Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
Medicine Products: